
Skift
Fosun Files for ClubMed IPO in Hong Kong
ClubMed's revenue rose less than 5% last year, suggesting that "premiumization" isn't delivering pricing power yet. An IPO would generate ca
Zum Angebot
ClubMed's revenue rose less than 5% last year, suggesting that "premiumization" isn't delivering pricing power yet. An IPO would generate ca
Zum Angebot